
CAS 915087-16-0
:Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-N-methyl-
Description:
Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-N-methyl- is a complex organic compound characterized by its unique structural features, including a benzamide core and a substituted imidazolidinyl moiety. The presence of a cyano group and a trifluoromethyl group contributes to its chemical reactivity and potential biological activity. This compound is likely to exhibit polar characteristics due to the presence of functional groups, which may influence its solubility in various solvents. The imidazolidinyl structure suggests potential applications in medicinal chemistry, possibly as a pharmaceutical agent. Additionally, the trifluoromethyl group is known to enhance lipophilicity and metabolic stability, making such compounds of interest in drug design. The thioxo group may also impart unique reactivity, potentially allowing for further chemical modifications. Overall, this compound's intricate structure and functional groups suggest a range of potential applications in chemical synthesis and pharmaceutical development.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-N-methylbenzamide
CAS:<p>4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-N-methylbenzamide</p>Purity:98%Molecular weight:446.45g/molDesfluoroenzalutamide
CAS:Formula:C21H17F3N4O2SColor and Shape:White To Off-White SolidMolecular weight:446.45Defluoro-MDV 3100 (Defluoro-enzalutamide)
CAS:Controlled Product<p>Applications Defluoro-MDV 3100 (Defluoro-enzalutamide) is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.<br>References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016);<br></p>Formula:C21H17F3N4O2SColor and Shape:Light YellowMolecular weight:446.45Defluoro-MDV 3100-d3 (Defluoro-enzalutamide-d3)
CAS:Controlled ProductFormula:C21D3H14F3N4O2SColor and Shape:NeatMolecular weight:449.464Desfluoro impurity
CAS:<p>Desfluoro impurity is a drug product that is an analytical standard for the identification of impurities in API. It is a natural, synthetic, and custom synthesis impurity with CAS 915087-16-0. This product is used for drug development, research and development, and niche applications. Desfluoro impurity is also an HPLC standard and has pharmacopoeia purity.</p>Formula:C21H17F3N4O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:446.45 g/mol





